The world of penny stocks is interesting, offering the promise of significant returns for those willing to dive into this niche market. There aren’t any guarantees that you’ll immediately hit it big as a trader. But there are things you can do the right way in order to research and find top names to add to your list of penny stocks.
One effective strategy to navigate these waters involves observing insider trading activities. Insider trading, in its legal form, happens when company insiders trade stocks within the bounds of regulatory compliance. For penny stock enthusiasts, these activities are not just transactions but clues pointing toward potentially undervalued or growth-ready stocks.
Identifying insider trading is like piecing together a financial puzzle. Key pieces are found in SEC filings, especially Forms 4 and 5, which insiders use to report their stock transactions. Nowadays, technology comes to the rescue, with various online platforms and financial services simplifying the tracking of these filings. Investing in penny stocks based on insider trading cues is a tightrope walk between risk and reward. Insider buying can hint at a company’s bright future, signaling a good time to invest.
– Are EV Penny Stocks Worth Buying?
However, insider selling isn’t always a red flag; it might be driven by personal reasons rather than company performance. The volatile nature of penny stocks adds another layer of risk, sheds light on the need for a well-thought-out investment strategy.
Penny Stocks To Buy According To Insiders
The SEC keeps tabs on insider trades to stop questionable activity. For investors, tracking these legal trades in public filings can be beneficial. It points to penny stocks that might be worth a look. Some stocks have had interesting insider trading activity lately. Here’s what insiders are doing with these penny stocks to watch in November.
Ondas Holdings Inc. (ONDS)
Ondas Holdings Inc. provides private industrial wireless networks and commercial drone and automated data solutions. They focus on developing and delivering mission-critical solutions to improve safety and efficiency. In addition to insider trading, ONDS stock has gained attention following its earnings update.
It reported its financial and operational results for the third quarter of 2023, highlighting significant achievements. The company achieved $10.7 million in year-to-date revenues, keeping it on track to meet its $15 million revenue target for 2023.
A 60% quarter-over-quarter growth in Ondas Networks revenue was driven by a record delivery of product shipments to Siemens, totaling $2.4 million. Ondas Autonomous Systems (OAS) also secured a substantial order worth $2.6 million for fleet expansion in Dubai, reflecting increased demand in the security and public safety markets.
– Best Penny Stocks To Buy This Week? 4 To Watch Now
So which insiders are buying shares of ONDS stock in November? One of the company’s 10% holders, Joseph Popolo is scooping up hundreds of thousands of shares. In total, for the month of November, he has purchased more than 410,000 shares.
Heron Therapeutics (HRTX)
Heron Therapeutics, Inc. is a commercial-stage biotechnology company developing and commercializing therapeutics for acute care and oncology patients. The company recently updated its financial guidance for 2023 and 2024. It now expects full-year 2023 net product sales to be between $123 million and $125 million, with an increase in oncology care franchise sales guidance from $99 million-$103 million to $104 million-$106 million.
For 2024, net product sales are expected to be between $138 million and $158 million, with the oncology care franchise anticipated to grow 3%-5%. Its acute care business is also showing signs of growth expected to be over 48% year-over-year. Full-year 2024 EBITDA (excluding stock compensation) is anticipated to be between ($22 million) and $3 million, showing a potential move towards profitability.
The company has put a cost reduction plan in place, decreasing operating expenses by 26% in 2023 compared to 2022. Operating expenses for 2024 are expected to be between $108 million and $116 million. The company also expects its gross margin to improve from 41% in 2023 to over 75% in 2025 and beyond.
As for insider trading, HRTX stock joins this list after its CFO, CEO and Chief Development Officers bought shares this month. Altogether, the three purchased over 280,000 shares in November. The largest buy came from CEO Craig Collard, with 150,000 shares bought at an average price of $0.9198.
Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. aims to rapidly develop medicines by taking advantage of their expertise in gene therapy drug development. Like many of the names on this list of penny stocks, the company reported financial results for the third quarter of 2023. As of September 30, 2023, the company had cash and cash equivalents of $164.3 million. This financial position is expected to fund their operating expenses and capital requirements into 2026.
– 11 Top Penny Stocks To Buy Now According To Insiders
Importantly, Taysha’s management discussed its pipeline progress. “Prior to initiating the REVEAL trial, the expectation of seeing a clinical benefit in adults with stage four Rett syndrome was low due to the advanced and relentless progression of the disease. We are highly encouraged by the positive 12-week data from the first adult patient and initial four-week data from the second adult patient in the low dose TSHA-102 cohort,” said Sean P. Nolan, Chairman and Chief Executive Officer of Taysha.”These early improvements in both patients, coupled with the sustained response through week 12 in the first patient, support the transformative potential of TSHA-102 across multiple genotypes of Rett syndrome.”
Who’s buying shares of TSHA stock today? One of the company’s 10% holders, Paul Manning, grabbed 100,000 shares of Taysha stock this month. Average prices ranged between $1.57 and $1.68 on November 17, 2023.
List Of Penny Stocks With Insider Buying
- Ondas Holdings Inc. (NASDAQ: ONDS)
- Heron Therapeutics (NASDAQ: HRTX)
- Taysha Gene Therapies, Inc. (NASDAQ: TSHA)
You made it to the end of the article! …Now What?
Start learning How To Trade From Professionals
True Trading Group, the fastest-growing & highest-rated online educational community, is now offering a 7-day trial of its platform, for Just A 1-TIME NO-AUTO UPGRADE & NO-AUTO RENEW PAYMENT OF JUST $3! Click Here For Full Details.
